<DOC>
	<DOC>NCT00226343</DOC>
	<brief_summary>Obtain information using a randomized treatment to assess the antidepressant and anxiolytic efficacy of divalproex vs. placebo for nonrefractory bipolar patients with major depressive episodes.</brief_summary>
	<brief_title>Depakote-ER for Depressive and Bipolar Depression</brief_title>
	<detailed_description>Study is 6 weeks long, with 7 clinical visits.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>DSMIV diagnosis of bipolar disorder type I or II, non refractory, nonpsychotic; females must be nonpregnant/nonlactating; sexually active females must use adequate contraception; MRS &lt; 12; MADRS &gt; 17; no other baseline mood stabilizing drugs, antidepressants or antipsychotics Active substance abuse or dependence in the past month; medically unstable condition; previously intolerance to valproate; past hepatitis B or C, or serious liver disease; serious suicidality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2006</verification_date>
</DOC>